Advancis Pharmaceutical is now MiddleBrook™ Pharmaceuticals, Inc.

In 2000, MiddleBrook Pharmaceuticals, Inc. made a novel discovery. Bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens.

Today, we are working to develop and commercialize pulsatile drug products, applying our patented finding to create a new outlook on anti-infective therapy.
+ Learn more.

Nov 19, 2008
MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
+ more info

Nov 13, 2008
MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
+ more info

Nov 06, 2008
MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents
+ more info